← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review Article (168)Early study (phase 1 or 2) (25)Description of individual patients (95)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (2000)

• Risk assessment of aflatoxin-related liver cancer in Bangladesh. (2019/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL. (2019/01/31) ♡
• Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients. (2019/01/13) ♡
• A case of chronic hepatitis B merged with acute fatty liver of pregnancy with severe coagulopathy. (2019/01/07) ♡
• Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Plasma CXCL13 is a predictive factor for HBsAg loss and clinical relapse after discontinuation of nucleos(t)ide analogue treatment. (2019/01/01) ♡
• Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. T cell dysfunction in chronic hepatitis B infection and liver cancer: evidence from transcriptome analysis. (2019/01/01) ♡
• Taiwan consensus statement on the management of chronic hepatitis B. (2019/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Response to Zhang et al. re:"CXCR5(+) CD8(+) T Cells Indirectly Offer B Cell Help and Are Inversely Correlated with Viral Load in Chronic Hepatitis B Infection". (2019/01/01) ♡
• Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation. (2019/01/01) ♡
• Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. (2019/01/01) ♡
• Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. (2019/01/01) ♡
• Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells. (2019/01/01) ♡
• Long term follow-up of children with chronic hepatitis B: a single center experience. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B. (2019/01/01) ♡
• Impact of Highly Active Antiretroviral Therapy on Chronic Hepatitis B Serological Markers among Senegalese HIV Co-infected Children. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Quantification of Hepatitis B Surface Antigen: Is there a Role in HIV-Hepatitis B Virus Coinfection? (2019/01/01) ♡
• Comparative study on guidelines in determining HBV phases in Iranian patients. (2019/01/01) ♡
• Risk factors of transmission and natural history of chronic hepatitis B infection in Iranian patients. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy (2019-12-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) (2019-12-19) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate (2019-12-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b (2019-12-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B (2019-12-16) ♡
• Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma. (2018/12/31) ♡
• Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. (2018/12/26) ♡
• Neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis and steatosis in patients with chronic hepatitis B. (2018/12/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia. (2018/12/17) ♡
• Measurement of hepatitis B virus DNA in fresh versus processed dentin from chronically infected patients. (2018/12/12) ♡
• Hepatitis B virus infection and development of chronic kidney disease: a cohort study. (2018/12/11) ♡
• Characterization of small genomic regions of the hepatitis B virus should be performed with more caution. (2018/12/10) ♡
• Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma. (2018/12/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Imatinib and liver toxicity. (2018/12/07) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Prevention of Mother-to-Child Transmission in Patients with Chronic Hepatitis B Virus Infection and High Viral Loads. (2018/12/06) ♡
• Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitis. (2018/12/05) ♡
• Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis. (2018/12/03) ♡
• A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K/AKT signaling pathways. (2018/12/01) ♡
• Development of a Dietary Methyl Donor Food Frequency Questionnaire to Assess Folate and Vitamin B(12) Status in Children with Chronic Hepatitis B Virus Infection. (2018/12/01) ♡
• Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity. (2018/12/01) ♡
• Molecular evolution and genomics of hepatitis B virus subgenotype C2 strain predominant in the chronic patients in Bangladesh. (2018/12/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Association of cytotoxic T-lymphocyte antigen-4 + 49A/G gene polymorphism with hepatocellular carcinoma risk in Chinese. (2018/12/01) ♡
• A promising non-invasive index for predicting liver inflammation in chronic hepatitis B patients with alanine aminotransferase ≤2 upper limit of normal. (2018/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma: A case report. (2018/12/01) ♡
• Oral oxymatrine for hepatitis B cirrhosis: A systematic review protocol. (2018/12/01) ♡
• Expressions of MiR-132 in patients with chronic hepatitis B, posthepatitic cirrhosis and hepatitis B virus-related hepatocellular carcinoma. (2018/12/01) ♡
• Management of Chronic Hepatitis B: Knowledge and Practices of Physicians in Pakistan. (2018/12/01) ♡
• Immune-tolerant Chronic Hepatitis B Infection-Is the Liver Really Tolerating? (2018/12/01) ♡
• INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosuppressants, or Corticosteroids. (2018/12/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Entecavir-based combination therapies for chronic hepatitis B: A meta-analysis. (2018/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.